Chronic lymphocytic leukaemia: open trials in Romania

10 open trials have a site in Romania. Registry data; only the trial team decides who can take part.

NCT06588478
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Trial Treatment · Phase 2 · Loxo Oncology, Inc.
Spitalul Clinic Colțea, Bucharest · Fundeni Clinical Institute, Bucharest · Institutul Oncologic Cluj, Cluj-Napoca · Spitalul Clinic Municipal Filantropia Craiova, Craiova · Institutul Regional de Oncologie, Iași · Ovidius Clinical Hospital OCH, Ovidiu
Registry updated 2026-11-04
NCT07602088
A Real-world Study of Ibrutinib and Venetoclax (I+V) First-Line Treatment Given for Fixed-duration of Time in Participants With Chronic Lymphocytic Leukemia
Research · Janssen Research & Development, LLC
Spitalul Universitar de Urgență București, Bucharest
Registry updated 2026-11-03
NCT04728893
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC
Centrul de Diagnostic si Tratament Oncologic Brasov (Site 1802), Brasov · Spitalul Clinic Colțea (Site 1805), Bucharest · Institutul Regional de Oncologie Iasi (Site 1801), Iași · Ovidius Clinical Hospital (Site 1804), Ovidiu
Registry updated 2026-10-27
NCT05645107
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
Trial Treatment · Phase 3 · Grifols Therapeutics LLC
Onco Card S.R.L., Brasov · Spitalul Clinic Colentina Bucuresti, Bucharest · Spitalul Universitar de Urgență București, Bucharest · Institutul Clinic Fundeni, Bucharest · Spitalul Clinic Colțea, Bucharest · Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca · Institutul Regional de Oncologie Iasi, Iași · Ovidius Clinical Hospital S.R.L, Ovidiu · Spitalul Clinic Municipal De Urgenta Timisoara, Timisoara
Registry updated 2026-09-30
NCT06973187
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Trial Treatment · Phase 3 · BeOne Medicines
Spitalul Clinic Colțea, Bucharest · Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca · Institutul Regional de Oncologie Iasi, Iași
Registry updated 2026-09-28
NCT07277231
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
Trial Treatment · Phase 3 · BeOne Medicines
Spitalul Clinic Colțea, Bucharest · Institutul Clinic Fundeni, Bucharest · Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca
Registry updated 2026-09-28
NCT06980116
Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies
Trial Treatment · Phase 1 · Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
Arensia Clinics S.R.L., Bucharest · Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca
Registry updated 2026-08-13
NCT06104566
Global Trial in APG2575 for Patients With CLL/SLL
Trial Treatment · Phase 3 · Ascentage Pharma Group Inc.
Institutul Clinic Fundeni, Bucharest · Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca · Spitalul Clinic Municipal De Urgenta Timisoara, Timisoara
Registry updated 2026-06-18
NCT05544019
Study of SGR-1505 in Mature B-Cell Neoplasms
Trial Treatment · Phase 1 · Schrödinger, Inc.
Institutul Oncologic Prof. Dr. Alexandru Trestioreanu Bucuresti, Bucharest · Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca
Registry updated 2026-02-13
NCT04895436
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Trial Treatment · Phase 2 · AbbVie
Global Medical Ultra S.R.L., Bucharest
Registry updated 2026-02-09

All Chronic lymphocytic leukaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error